BLOGS WEBSITE

US NIH National Institute of Allergy and Infectious Diseases: Fc-Dependent Mechanisms of Antibody-Mediated Killing – U01, R21, and R21 (AIDS-related) mechanisms

 

The following opportunities have recently been announced by the US National Institute of Allergy and Infectious Diseases, under the scheme Fc-dependent mechanisms of antibody-mediated killing.

Please note: due dates vary according to mechanism.

 U01 (clinical trial not allowed)
This supports a group of specialised collaboratories that will seek to accelerate progress towards establishing comprehensive molecular and anatomical reference cell atlases of human brains and non-human primate brains.

R21 (clinical trial not allowed)
This supports research that aims to improve the understanding of Fc-dependent, antibody-mediated killing of pathogen-infected or otherwise dysregulated host cells.

R21  – AIDS-related (clinical trial not allowed)
This supports AIDS-related research that aims to improve the understanding of Fc-dependent, antibody-mediated killing of pathogen-infected or otherwise dysregulated host cells.

Eligibility

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submissions

Please contact rbinternational@adelaide.edu.au if you are considering an application for any of these schemes.

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences and tagged . Bookmark the permalink.
 

Comments are closed.